CM
CELL

Crystalline Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Crystalline Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,211,994
Closed -$1.21M – 144
2023
Q3 		$1.21M Buy
1,211,994
+1,199,902
+9,923% +$920K 0.87% 37
2023
Q2 		$5.92K Buy
+12,092
New +$9.89K ﹤0.01% 94

Crystalline Management's CELL Position: Q4 2023 in Review

Crystalline Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 1,211,994 shares — an estimated $1.21M sold.

Crystalline Management first reported a position in CELL in Q2 2023 and held it in 2 quarters. The position peaked at $1.21M in Q3 2023. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Crystalline Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Crystalline Management sold 1,211,994 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $1.21M.
  • Crystalline Management first reported a position in PhenomeX Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Crystalline Management's PhenomeX Inc. Common Stock position peaked at $1.21M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Crystalline Management's 13F filing for Q4 2023, filed 12 Feb 2024.